Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Oncology Reports

Issue 5/2010

Content (9 Articles)

Clinical Trial Report

Limited Resection for Early-Stage Lung Cancer

Tarek Mekhail, Joseph Boyer

Clinical Trial Report

Indoor Tanning and Substance-Related Disorder—Related Behaviors With Similar Treatment?

Kim A. Margolin

Clinical Trial Report

Indoor Tanning Use Among U.S. Youth—Can Skin Health Behaviors be Legislated?

Kim A. Margolin

Haploidentical Transplantation for Leukemia

Junya Kanda, Nelson J. Chao, David A. Rizzieri

Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the “Best” Therapy?

Meetu Agrawal, Ravin J. Garg, Hagop Kantarjian, Jorge Cortes

Open Access

A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers

Olivia M. Lucero, David W. Dawson, Randall T. Moon, Andy J. Chien

How Sunlight Causes Melanoma

Lilit Garibyan, David E. Fisher

Small Cell Lung Cancer: Past, Present, and Future

Estelamari Rodriguez, Rogerio C. Lilenbaum

Molecular Testing in Lung Cancer: The Time Is Now

Haiying Cheng, Xunhai Xu, Daniel B. Costa, Charles A. Powell, Balazs Halmos

Jul 10
Issue: 4/2010
Nov 10
Issue: 6/2010

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits